FLASH NEWS LIVE

US proposal to halve biosimilar development costs for Biocon, top exec says

US proposal to halve biosimilar development costs for Biocon, top exec says

Biosimilars are copies of costlier biological drugs used to treat major illnesses such as cancer, rheumatoid arthritis, psoriasis and diabetes

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp